Table 5.
Comparison of secondary outcome in BST arm and convalescent plasma arm
| Characteristics | BST arm (n = 133) | MIP arm (n = 91) | p |
|---|---|---|---|
| Resolution of cough on 5th day; n (%) | 85 (63.90%) | 67 (73.62%) | 0.43 |
| Resolution of fever on 5th day; n (%) | 95 (71.42%) | 66 (72.52%) | 0.82 |
| Resolution of myalgia on 5th day; n (%) | 58 (43.60%) | 87 (95.60%) | ≤0.01 |
| Resolution of sore throat on 5th day; n (%) | 62 (46.61%) | 71 (78.02%) | ≤0.01 |
| Resolution of shortness of breath on 5th day; n (%) | 39 (29.32%) | 73 (80.21%) | ≤0.01 |
| Days of respiratory support postenrollment | 65 (48.87%) | 56 (61.53%) | ≤0.05 |
| Need for invasive mechanical ventilation on 5th day postenrollment; n (%) | 71 (53.38%) | 35 (38.46%) | ≤0.01 |
Abbreviations: BST, best standard treatment; MIP, Mycobacterium indicus pranii.